|
SB 1404 - Memory Care
Requires new memory care services licenses for assisted living facilities providing specialized Alzheimer’s care and establishes the Florida Alzheimer’s Center of Excellence to support individuals with related dementias and their caregivers.
- Defines “memory care resident” and “memory care services” to distinguish specialized care from optional supportive services.
- Adds a memory care services license category for assisted living facilities that serve memory care residents or market such services.
- Mandates that facilities meet additional requirements established by the Agency for Health Care Administration, including staff training, safety measures, and physical plant standards.
- Allows existing facilities to continue serving current memory care residents under specific conditions if they cannot obtain a memory care license immediately.
- Creates the Florida Alzheimer’s Center of Excellence to provide caregiver assessments, personalized plans, and state-level coordination of resources for individuals with Alzheimer’s disease or related dementias.
SB 902 - Department of Health
Revises medical marijuana regulations, updates pediatric service transitions, establishes a new neurofibromatosis research grant program, and modifies licensure and training requirements for health care practitioners.
- Redefines “low-THC cannabis” with updated THC and CBD thresholds and excludes edibles.
- Requires qualified physicians and medical directors to renew their certification biennially, removing outdated reference to active orders.
- Prohibits new cultivation, processing, or dispensing facilities within specified distances of parks, child care, and early learning facilities, while exempting previously approved facilities and allowing local government waivers.
- Creates the Neurofibromatosis Disease Grant Program to fund scientific and clinical research.
- Revises Early Steps Program to standardize transition protocols for infants and toddlers with disabilities and expands dispute resolution procedures.
- Mandates emergency license suspension for health care practitioners arrested for murder or related offenses.
- Allows registered nurses to delegate the administration of certain controlled substances to home health aides for medically fragile children.
- Extends the completion deadline for marriage and family therapist licensure requirements from 2027 to 2032.
- Broadens eligibility for the autism micro-credential to include Early Steps credentialed providers.
HB 1443 - Parkinson's Disease Registry
CS/CS/CS/HB 1443 requires the Florida Institute for Parkinson’s Disease (Institute) within the University of South Florida (USF) to establish a statewide Parkinson’s disease registry.
- The bill requires physicians and advanced practice registered nurses who diagnose or treat a patient with Parkinson’s disease or atypical parkinsonism to report nationally recognized performance measures to the registry beginning January 1, 2027, and grants them liability protection for doing so.
- The Parkinson’s Disease Research Board (Board) must submit annual reports on the registry data to the Governor, President of the Senate, and the Speaker of the House of Representatives beginning October 15, 2028.
- The bill requires the Institute to create and maintain a public website dedicated to the Parkinson’s disease registry beginning January 1, 2028, to be updated yearly.
- The website must include, at a minimum, downloadable annual reports on the incidence and prevalence of Parkinson's disease and atypical parkinsonism, information on the Consortium for Parkinson’s Disease Research, and other information as determined by the Board.
HB 1425 - Consultant Pharmacists
CS/HB 1425 allows a consultant pharmacist to provide medication management services at health care clinics that are owned by a hospital or at least one physician that is employed by or contracted with a hospital.
SB 1092 - Podiatric Medicine
Podiatric physicians: establish legal parameters for using cellular or tissue-based products under specified conditions.
- Authorizes the use of certain unapproved cellular or tissue-based products by qualifying podiatric physicians for specified treatment purposes such as connective tissue repair, wound care, and pain management.
- Requires that such cellular or tissue-based products come from facilities registered with the FDA and meet specific accreditation and viability standards.
- Mandates inclusion of a clear statutory notice in all forms of advertisement regarding non-FDA-approved cellular or tissue-based products.
- Establishes a signed consent requirement informing patients of procedure details, risks, benefits, and the unapproved status of the products.
- Sets criminal penalties and disciplinary actions for prohibited uses, including procedures involving fetal cells from abortions or distributing certain products created from human tissues.
SB 844 - Sickle Cell Disease Care Management and Treatment Continuing Education
CS/SB 844 amends s. 456.0301, F.S., to require that the standard continuing education (CE) course on prescribing controlled substances must include information regarding the treatment of pain for patients with sickle cell disease.
SB 1506 - Civil Litigation
- Revises the criteria for courts to consider in determining whether a civil damages award is excessive or inadequate.
- Updates statutory language by clarifying and modernizing references to the court’s responsibilities in reviewing civil damages awards.
- Adds new factors for determining whether noneconomic damages have a rational, evidence-based connection to the injuries suffered.
- Applies these revised standards to pending and future causes of action.
- Incorporates these changes in existing statutes that reference the court’s role in reviewing punitive and compensatory damages awards.
HB 1201 - Student Health and Safety
Expands Department of Health responsibilities and revises school requirements for educating, training, and informing staff and students about epilepsy and seizure disorders.
- Requires the department to include the new epilepsy and seizure training requirements in its educational program.
- Mandates that a student’s individualized seizure action plan (ISAP) be developed and signed by a medical professional, in a form determined by that professional, in consultation with the student’s parent.
- Expands the list of school employees who must complete seizure care training to include those who transport students, and makes this training valid for five years.
- Requires schools to display a specified poster outlining steps to respond to a person having a seizure.
SB 42 - Specific Medical Diagnoses in Child Protective Investigations
Clarify how child protective investigations address certain preexisting medical diagnoses by adjusting reporting requirements, mandating additional medical consultation, and establishing rights for second opinions.
SB 878 - Clinical Laboratory Personnel
Streamline clinical laboratory personnel licensure by recognizing federal qualifications, requiring proof of eligibility, and mandating payment of specified fees.
- Requires proof of qualification, submission of background screening, and payment of required fees for applicants eligible under specified statutory provisions.
- Deems applicants who meet federal requirements for high-complexity testing to have satisfied minimum state qualifications for licensure as technologists or technicians.
- Deems applicants who meet federal requirements for moderate-complexity testing to have satisfied minimum state qualifications for licensure as technicians.
SB 914 - Dry Needling
Define dry needling terms under occupational therapy and require additional training and supervision for occupational therapists performing this procedure.
- Adds definitions for “dry needling” and “myofascial trigger point” to the Occupational Therapy Practice Act.
- Creates new standards requiring minimum licensed practice experience, face-to-face continuing education with psychomotor skill assessment, and 25 supervised patient sessions.
- Allows the Board of Occupational Therapy to set additional requirements for dry needling of the head, neck, or torso if safety warrants it.
- Mandates informed consent and prohibits delegation of dry needling to nonqualified individuals.
- Directs the Department of Health to report on licensed occupational therapists who perform dry needling, including any adverse incidents.
SB 1168 - Background Screenings
Expand level 2 background screening requirements, add new disqualifying offenses, and revise clearinghouse procedures for determining eligibility.
- Adds offenses such as DUI manslaughter, computer-related crimes, and threats or extortion to the list of disqualifying background screening offenses and renumbers the existing domestic violence subsection.
- Requires the Agency for Health Care Administration to conduct eligibility determinations for criminal history checks submitted to the Care Provider Background Screening Clearinghouse and to share these determinations with specified agencies and qualified entities.
- Authorizes the clearinghouse to provide national criminal history record information to qualified entities and requires each qualified entity to appoint a user administrator for compliance and security purposes.
- Prevents individuals from denying or failing to acknowledge certain sealed or expunged records when screened through the clearinghouse by a specified agency or qualified entity.
SB 196 - Uterine Fibroid Research Database
Remove the prohibition on including personally identifying information in the uterine fibroid research database.
HB 743 - Prohibited Sex-reassignment Prescriptions and Procedures
Prohibits aiding or abetting restricted sex-reassignment interventions to a patient younger than 18 years of age and authorizes the Attorney General to pursue civil action and damages in such cases.
|